VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 126 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $860,520 | +3.4% | 108,789 | +21.7% | 0.00% | – |
| Q1 2024 | $831,988 | +10.3% | 89,365 | 0.0% | 0.00% | – |
| Q4 2023 | $754,241 | +10.1% | 89,365 | +1.1% | 0.00% | – |
| Q3 2023 | $685,294 | -32.3% | 88,425 | 0.0% | 0.00% | – |
| Q2 2023 | $1,012,467 | +140.5% | 88,425 | -1.1% | 0.00% | – |
| Q1 2021 | $421,000 | -36.7% | 89,401 | -4.0% | 0.00% | – |
| Q4 2020 | $665,000 | -77.3% | 93,082 | -66.1% | 0.00% | -100.0% |
| Q3 2020 | $2,927,000 | -43.1% | 274,305 | -32.7% | 0.00% | -50.0% |
| Q2 2020 | $5,142,000 | +35.5% | 407,439 | -1.8% | 0.00% | 0.0% |
| Q1 2020 | $3,795,000 | -34.4% | 414,749 | -0.1% | 0.00% | 0.0% |
| Q4 2019 | $5,789,000 | -35.6% | 414,973 | -20.5% | 0.00% | -50.0% |
| Q3 2019 | $8,985,000 | +28.2% | 522,059 | +102.8% | 0.00% | +33.3% |
| Q2 2019 | $7,009,000 | – | 257,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $37,772,000 | 15.45% |
| EcoR1 Capital, LLC | 4,753,907 | $28,096,000 | 0.97% |
| ARMISTICE CAPITAL, LLC | 2,564,000 | $15,153,000 | 0.26% |
| Harvest Investment Services, LLC | 42,312 | $250,000 | 0.19% |
| Aevitas Wealth Management, Inc. | 22,000 | $130,000 | 0.09% |
| CAXTON ASSOCIATES LP | 136,592 | $807,000 | 0.08% |
| XTX Topco Ltd | 25,525 | $151,000 | 0.06% |
| BVF INC/IL | 140,000 | $827,000 | 0.04% |
| FIDUCIARY TRUST CO | 248,529 | $1,469,000 | 0.03% |
| MYDA Advisors LLC | 12,000 | $71,000 | 0.02% |